- Home
- BSRR vs SAGE Comparison
BSRR vs SAGE Comparison
Compare BSRR & SAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSRR
- SAGE
- Stock Information
- Founded
- BSRR 1977
- SAGE 2010
- Country
- BSRR United States
- SAGE United States
- Employees
- BSRR N/A
- SAGE N/A
- Industry
- BSRR Major Banks
- SAGE Biotechnology: Pharmaceutical Preparations
- Sector
- BSRR Finance
- SAGE Health Care
- Exchange
- BSRR Nasdaq
- SAGE Nasdaq
- Market Cap
- BSRR 349.2M
- SAGE 413.9M
- IPO Year
- BSRR 1994
- SAGE 2014
- Fundamental
- Price
- BSRR $26.99
- SAGE $6.54
- Analyst Decision
- BSRR Buy
- SAGE Hold
- Analyst Count
- BSRR 2
- SAGE 19
- Target Price
- BSRR $33.50
- SAGE $9.88
- AVG Volume (30 Days)
- BSRR 29.2K
- SAGE 732.4K
- Earning Date
- BSRR 07-21-2025
- SAGE 07-30-2025
- Dividend Yield
- BSRR 3.69%
- SAGE N/A
- EPS Growth
- BSRR 17.05
- SAGE N/A
- EPS
- BSRR 2.83
- SAGE N/A
- Revenue
- BSRR $144,262,000.00
- SAGE $47,404,000.00
- Revenue This Year
- BSRR $7.34
- SAGE $101.76
- Revenue Next Year
- BSRR $4.89
- SAGE $41.18
- P/E Ratio
- BSRR $9.70
- SAGE N/A
- Revenue Growth
- BSRR 1.70
- SAGE N/A
- 52 Week Low
- BSRR $19.77
- SAGE $4.62
- 52 Week High
- BSRR $35.13
- SAGE $13.47
- Technical
- Relative Strength Index (RSI)
- BSRR 46.06
- SAGE 41.95
- Support Level
- BSRR $26.86
- SAGE $6.35
- Resistance Level
- BSRR $27.70
- SAGE $6.73
- Average True Range (ATR)
- BSRR 0.68
- SAGE 0.24
- MACD
- BSRR -0.12
- SAGE 0.01
- Stochastic Oscillator
- BSRR 8.87
- SAGE 21.11
About BSRR Sierra Bancorp
Sierra Bancorp is a California-based bank holding company, which offers a range of retail and commercial banking services. it offers a wide range of deposit products and services for individuals and businesses including checking accounts, savings accounts, money market demand accounts, time deposits, retirement accounts, and sweep accounts. The company's lending activities cover real estate, commercial (including small business), mortgage warehouse, agricultural and consumer loans, and also offers commercial construction loans and multifamily and agricultural credit facilities among other types of real estate loans.
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.